Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Editorial: Next-Generation Probiotics: From Commensal Bacteria to Novel Drugs and Food Supplements.

Langella P, Guarner F, Martín R.

Front Microbiol. 2019 Aug 27;10:1973. doi: 10.3389/fmicb.2019.01973. eCollection 2019. No abstract available.

2.

The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model.

Escribano-Vazquez U, Verstraeten S, Martin R, Chain F, Langella P, Thomas M, Cherbuy C.

Sci Rep. 2019 Aug 7;9(1):11431. doi: 10.1038/s41598-019-47611-9.

3.

Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host.

Lavelle A, Hoffmann TW, Pham HP, Langella P, Guédon E, Sokol H.

Microbiome. 2019 Aug 2;7(1):111. doi: 10.1186/s40168-019-0725-3.

4.

Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiota.

Breyner NM, Vilas Boas PB, Fernandes G, de Carvalho RD, Rochat T, Michel ML, Chain F, Sokol H, de Azevedo M, Myioshi A, Azevedo VA, Langella P, Bermúdez-Humarán LG, Chatel JM.

Environ Microbiol. 2019 Jul 19. doi: 10.1111/1462-2920.14748. [Epub ahead of print]

PMID:
31325218
5.

Modulation of the Caecal Gut Microbiota of Mice by Dietary Supplement Containing Resistant Starch: Impact Is Donor-Dependent.

Cherbuy C, Bellet D, Robert V, Mayeur C, Schwiertz A, Langella P.

Front Microbiol. 2019 Jun 6;10:1234. doi: 10.3389/fmicb.2019.01234. eCollection 2019.

6.

Emerging Health Concepts in the Probiotics Field: Streamlining the Definitions.

Martín R, Langella P.

Front Microbiol. 2019 May 21;10:1047. doi: 10.3389/fmicb.2019.01047. eCollection 2019. No abstract available.

7.

The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response.

Martín R, Chamignon C, Mhedbi-Hajri N, Chain F, Derrien M, Escribano-Vázquez U, Garault P, Cotillard A, Pham HP, Chervaux C, Bermúdez-Humarán LG, Smokvina T, Langella P.

Sci Rep. 2019 Apr 1;9(1):5398. doi: 10.1038/s41598-019-41738-5.

8.

A Putative Type V Pilus Contributes to Bacteroides thetaiotaomicron Biofilm Formation Capacity.

Mihajlovic J, Bechon N, Ivanova C, Chain F, Almeida A, Langella P, Beloin C, Ghigo JM.

J Bacteriol. 2019 Aug 22;201(18). pii: e00650-18. doi: 10.1128/JB.00650-18. Print 2019 Sep 15.

PMID:
30833358
9.

Anti-tumoral Effects of Recombinant Lactococcus lactis Strain Secreting IL-17A Cytokine.

Jacouton E, Torres Maravilla E, Boucard AS, Pouderous N, Pessoa Vilela AP, Naas I, Chain F, Azevedo V, Langella P, Bermúdez-Humarán LG.

Front Microbiol. 2019 Jan 23;9:3355. doi: 10.3389/fmicb.2018.03355. eCollection 2018.

10.

Risk assessment of probiotics use requires clinical parameters.

Langella P, Chatel JM.

Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):202-204. doi: 10.1038/s41575-019-0111-4. No abstract available.

PMID:
30692658
11.

Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties.

Jacouton E, Michel ML, Torres-Maravilla E, Chain F, Langella P, Bermúdez-Humarán LG.

Front Microbiol. 2019 Jan 11;9:3281. doi: 10.3389/fmicb.2018.03281. eCollection 2018.

12.

A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum.

Mauras A, Chain F, Faucheux A, Ruffié P, Gontier S, Ryffel B, Butel MJ, Langella P, Bermúdez-Humarán LG, Waligora-Dupriet AJ.

Front Microbiol. 2018 Dec 21;9:3075. doi: 10.3389/fmicb.2018.03075. eCollection 2018.

13.

Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity.

Kayser BD, Lhomme M, Prifti E, Da Cunha C, Marquet F, Chain F, Naas I, Pelloux V, Dao MC, Kontush A, Rizkalla SW, Aron-Wisnewsky J, Bermúdez-Humarán LG, Oakley F, Langella P, Clément K, Dugail I.

FASEB J. 2019 Apr;33(4):4741-4754. doi: 10.1096/fj.201801897R. Epub 2019 Jan 4.

PMID:
30608881
14.

M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.

Takahashi K, Yano A, Watanabe S, Langella P, Bermúdez-Humarán LG, Inoue N.

Appl Microbiol Biotechnol. 2018 Dec;102(24):10703-10711. doi: 10.1007/s00253-018-9427-1. Epub 2018 Oct 11.

PMID:
30310964
15.

Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP.

Carvalho R, Vaz A, Pereira FL, Dorella F, Aguiar E, Chatel JM, Bermudez L, Langella P, Fernandes G, Figueiredo H, Goes-Neto A, Azevedo V.

Sci Rep. 2018 Oct 10;8(1):15072. doi: 10.1038/s41598-018-33469-w.

16.

The regenerating family member 3 β instigates IL-17A-mediated neutrophil recruitment downstream of NOD1/2 signalling for controlling colonisation resistance independently of microbiota community structure.

Waldschmitt N, Kitamoto S, Secher T, Zacharioudaki V, Boulard O, Floquet E, Delacre M, Lamas B, Pham HP, Six A, Richard ML, Dagorn JC, Eberl G, Langella P, Chatel JM, Ryffel B, Iovanna JL, Poulin LF, Sokol H, Kamada N, Chamaillard M.

Gut. 2019 Jul;68(7):1190-1199. doi: 10.1136/gutjnl-2018-316757. Epub 2018 Oct 2.

PMID:
30279238
17.

Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma.

Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S, Remot A, Thomas M.

Front Physiol. 2018 Aug 21;9:1168. doi: 10.3389/fphys.2018.01168. eCollection 2018. Review.

18.

Characterization of a Prophage-Free Derivative Strain of Lactococcus lactis ssp. lactis IL1403 Reveals the Importance of Prophages for Phenotypic Plasticity of the Host.

Aucouturier A, Chain F, Langella P, Bidnenko E.

Front Microbiol. 2018 Aug 31;9:2032. doi: 10.3389/fmicb.2018.02032. eCollection 2018.

19.

Live bacterial biotherapeutics in the clinic.

Bermúdez-Humarán LG, Langella P.

Nat Biotechnol. 2018 Sep 6;36(9):816-818. doi: 10.1038/nbt.4248. No abstract available.

PMID:
30188536
20.

Enterobacteriaceae are essential for the modulation of colitis severity by fungi.

Sovran B, Planchais J, Jegou S, Straube M, Lamas B, Natividad JM, Agus A, Dupraz L, Glodt J, Da Costa G, Michel ML, Langella P, Richard ML, Sokol H.

Microbiome. 2018 Sep 1;6(1):152. doi: 10.1186/s40168-018-0538-9.

21.

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome.

Natividad JM, Agus A, Planchais J, Lamas B, Jarry AC, Martin R, Michel ML, Chong-Nguyen C, Roussel R, Straube M, Jegou S, McQuitty C, Le Gall M, da Costa G, Lecornet E, Michaudel C, Modoux M, Glodt J, Bridonneau C, Sovran B, Dupraz L, Bado A, Richard ML, Langella P, Hansel B, Launay JM, Xavier RJ, Duboc H, Sokol H.

Cell Metab. 2018 Nov 6;28(5):737-749.e4. doi: 10.1016/j.cmet.2018.07.001. Epub 2018 Jul 26.

PMID:
30057068
22.

Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice.

Natividad JM, Lamas B, Pham HP, Michel ML, Rainteau D, Bridonneau C, da Costa G, van Hylckama Vlieg J, Sovran B, Chamignon C, Planchais J, Richard ML, Langella P, Veiga P, Sokol H.

Nat Commun. 2018 Jul 18;9(1):2802. doi: 10.1038/s41467-018-05249-7.

23.

Food-grade TiO2 is trapped by intestinal mucus in vitro but does not impair mucin O-glycosylation and short-chain fatty acid synthesis in vivo: implications for gut barrier protection.

Talbot P, Radziwill-Bienkowska JM, Kamphuis JBJ, Steenkeste K, Bettini S, Robert V, Noordine ML, Mayeur C, Gaultier E, Langella P, Robbe-Masselot C, Houdeau E, Thomas M, Mercier-Bonin M.

J Nanobiotechnology. 2018 Jun 19;16(1):53. doi: 10.1186/s12951-018-0379-5.

24.

Toxicity of Food-Grade TiO2 to Commensal Intestinal and Transient Food-Borne Bacteria: New Insights Using Nano-SIMS and Synchrotron UV Fluorescence Imaging.

Radziwill-Bienkowska JM, Talbot P, Kamphuis JBJ, Robert V, Cartier C, Fourquaux I, Lentzen E, Audinot JN, Jamme F, Réfrégiers M, Bardowski JK, Langella P, Kowalczyk M, Houdeau E, Thomas M, Mercier-Bonin M.

Front Microbiol. 2018 Apr 24;9:794. doi: 10.3389/fmicb.2018.00794. eCollection 2018.

25.

Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.

Bindels LB, Neyrinck AM, Loumaye A, Catry E, Walgrave H, Cherbuy C, Leclercq S, Van Hul M, Plovier H, Pachikian B, Bermúdez-Humarán LG, Langella P, Cani PD, Thissen JP, Delzenne NM.

Oncotarget. 2018 Apr 6;9(26):18224-18238. doi: 10.18632/oncotarget.24804. eCollection 2018 Apr 6.

26.

A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain.

Barone M, Chain F, Sokol H, Brigidi P, Bermúdez-Humarán LG, Langella P, Martín R.

Front Microbiol. 2018 Mar 27;9:565. doi: 10.3389/fmicb.2018.00565. eCollection 2018.

27.

Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes.

Cornuault JK, Petit MA, Mariadassou M, Benevides L, Moncaut E, Langella P, Sokol H, De Paepe M.

Microbiome. 2018 Apr 3;6(1):65. doi: 10.1186/s40168-018-0452-1.

28.

Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii.

Martín R, Bermúdez-Humarán LG, Langella P.

Front Microbiol. 2018 Mar 6;9:346. doi: 10.3389/fmicb.2018.00346. eCollection 2018.

29.

Bile Salt Hydrolase Activities: A Novel Target to Screen Anti-Giardia Lactobacilli?

Allain T, Chaouch S, Thomas M, Travers MA, Valle I, Langella P, Grellier P, Polack B, Florent I, Bermúdez-Humarán LG.

Front Microbiol. 2018 Feb 8;9:89. doi: 10.3389/fmicb.2018.00089. eCollection 2018.

30.

Bile-Salt-Hydrolases from the Probiotic Strain Lactobacillus johnsonii La1 Mediate Anti-giardial Activity in Vitro and in Vivo.

Allain T, Chaouch S, Thomas M, Vallée I, Buret AG, Langella P, Grellier P, Polack B, Bermúdez-Humarán LG, Florent I.

Front Microbiol. 2018 Jan 31;8:2707. doi: 10.3389/fmicb.2017.02707. eCollection 2017.

31.

Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer.

Jacouton E, Chain F, Sokol H, Langella P, Bermúdez-Humarán LG.

Front Immunol. 2017 Nov 17;8:1553. doi: 10.3389/fimmu.2017.01553. eCollection 2017.

32.

Opposing effect of Lactobacillus on in vitro Klebsiella pneumoniae in biofilm and in an in vivo intestinal colonisation model.

Lagrafeuille R, Miquel S, Balestrino D, Vareille-Delarbre M, Chain F, Langella P, Forestier C.

Benef Microbes. 2018 Jan 29;9(1):87-100. doi: 10.3920/BM2017.0002. Epub 2017 Oct 12.

PMID:
29022382
33.

New Insights into the Diversity of the Genus Faecalibacterium.

Benevides L, Burman S, Martin R, Robert V, Thomas M, Miquel S, Chain F, Sokol H, Bermudez-Humaran LG, Morrison M, Langella P, Azevedo VA, Chatel JM, Soares S.

Front Microbiol. 2017 Sep 22;8:1790. doi: 10.3389/fmicb.2017.01790. eCollection 2017.

34.

Towards standards for human fecal sample processing in metagenomic studies.

Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, Tramontano M, Driessen M, Hercog R, Jung FE, Kultima JR, Hayward MR, Coelho LP, Allen-Vercoe E, Bertrand L, Blaut M, Brown JRM, Carton T, Cools-Portier S, Daigneault M, Derrien M, Druesne A, de Vos WM, Finlay BB, Flint HJ, Guarner F, Hattori M, Heilig H, Luna RA, van Hylckama Vlieg J, Junick J, Klymiuk I, Langella P, Le Chatelier E, Mai V, Manichanh C, Martin JC, Mery C, Morita H, O'Toole PW, Orvain C, Patil KR, Penders J, Persson S, Pons N, Popova M, Salonen A, Saulnier D, Scott KP, Singh B, Slezak K, Veiga P, Versalovic J, Zhao L, Zoetendal EG, Ehrlich SD, Dore J, Bork P.

Nat Biotechnol. 2017 Nov;35(11):1069-1076. doi: 10.1038/nbt.3960. Epub 2017 Oct 2.

PMID:
28967887
35.

Use of Traditional and Genetically Modified Probiotics in Human Health: What Does the Future Hold?

Bermúdez-Humarán LG, Langella P.

Microbiol Spectr. 2017 Sep;5(5). doi: 10.1128/microbiolspec.BAD-0016-2016. Review.

PMID:
28959936
36.

Mucosa-associated microbiota dysbiosis in colitis associated cancer.

Richard ML, Liguori G, Lamas B, Brandi G, da Costa G, Hoffmann TW, Pierluigi Di Simone M, Calabrese C, Poggioli G, Langella P, Campieri M, Sokol H.

Gut Microbes. 2018 Mar 4;9(2):131-142. doi: 10.1080/19490976.2017.1379637. Epub 2017 Oct 12.

37.

Using murine colitis models to analyze probiotics-host interactions.

Martín R, Chain F, Miquel S, Motta JP, Vergnolle N, Sokol H, Langella P.

FEMS Microbiol Rev. 2017 Aug 1;41(Supp_1):S49-S70. doi: 10.1093/femsre/fux035. Review.

PMID:
28830096
38.

Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence.

Lamas B, Michel ML, Waldschmitt N, Pham HP, Zacharioudaki V, Dupraz L, Delacre M, Natividad JM, Costa GD, Planchais J, Sovran B, Bridonneau C, Six A, Langella P, Richard ML, Chamaillard M, Sokol H.

Gut. 2018 Oct;67(10):1836-1844. doi: 10.1136/gutjnl-2017-314195. Epub 2017 Aug 8.

PMID:
28790160
39.

A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor.

McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, Duboux S, Steinmann M, Delley M, Tangyu M, Langella P, Mercenier A, Bergonzelli G, Verdu EF.

Appl Environ Microbiol. 2017 Sep 15;83(19). pii: e01323-17. doi: 10.1128/AEM.01323-17. Print 2017 Oct 1.

40.

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic.

Martín R, Miquel S, Benevides L, Bridonneau C, Robert V, Hudault S, Chain F, Berteau O, Azevedo V, Chatel JM, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P.

Front Microbiol. 2017 Jun 30;8:1226. doi: 10.3389/fmicb.2017.01226. eCollection 2017.

41.

Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.

Breban M, Tap J, Leboime A, Said-Nahal R, Langella P, Chiocchia G, Furet JP, Sokol H.

Ann Rheum Dis. 2017 Sep;76(9):1614-1622. doi: 10.1136/annrheumdis-2016-211064. Epub 2017 Jun 12.

PMID:
28606969
42.

Contribution of plasmid-encoded peptidase S8 (PrtP) to adhesion and transit in the gut of Lactococcus lactis IBB477 strain.

Radziwill-Bienkowska JM, Robert V, Drabot K, Chain F, Cherbuy C, Langella P, Thomas M, Bardowski JK, Mercier-Bonin M, Kowalczyk M.

Appl Microbiol Biotechnol. 2017 Jul;101(14):5709-5721. doi: 10.1007/s00253-017-8334-1. Epub 2017 May 24.

43.

Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.

Carvalho RDO, do Carmo FLR, de Oliveira Junior A, Langella P, Chatel JM, Bermúdez-Humarán LG, Azevedo V, de Azevedo MS.

Front Microbiol. 2017 May 9;8:800. doi: 10.3389/fmicb.2017.00800. eCollection 2017. Review.

44.

Plasmid transfer efficiency using Lactoccocus lactis strains depends on invasiveness status but also on plasmid copy number.

Mariat D, Robert V, Langella P, Chatel JM.

FEMS Microbiol Lett. 2017 Aug 1;364(14). doi: 10.1093/femsle/fnx100.

PMID:
28505315
45.

Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria.

LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P.

Microb Cell Fact. 2017 May 8;16(1):79. doi: 10.1186/s12934-017-0691-z. Review.

46.

Intestinal dendritic cell licensing through Toll-like receptor 4 is required for oral tolerance in allergic contact dermatitis.

Hacini-Rachinel F, Gomez de Agüero M, Kanjarawi R, Moro-Sibilot L, Le Luduec JB, Macari C, Boschetti G, Bardel E, Langella P, Dubois B, Kaiserlian D.

J Allergy Clin Immunol. 2018 Jan;141(1):163-170. doi: 10.1016/j.jaci.2017.02.022. Epub 2017 Mar 22.

PMID:
28342908
47.

Contribution of sortase SrtA2 to Lactobacillus casei BL23 inhibition of Staphylococcus aureus internalization into bovine mammary epithelial cells.

Souza RF, Jardin J, Cauty C, Rault L, Bouchard DS, Bermúdez-Humarán LG, Langella P, Monedero V, Seyffert N, Azevedo V, Le Loir Y, Even S.

PLoS One. 2017 Mar 21;12(3):e0174060. doi: 10.1371/journal.pone.0174060. eCollection 2017.

48.

Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway.

Breyner NM, Michon C, de Sousa CS, Vilas Boas PB, Chain F, Azevedo VA, Langella P, Chatel JM.

Front Microbiol. 2017 Feb 1;8:114. doi: 10.3389/fmicb.2017.00114. eCollection 2017.

49.

A Cell-Penetrant Manganese Superoxide Dismutase (MnSOD) Mimic Is Able To Complement MnSOD and Exerts an Antiinflammatory Effect on Cellular and Animal Models of Inflammatory Bowel Diseases.

Mathieu E, Bernard AS, Delsuc N, Quévrain E, Gazzah G, Lai B, Chain F, Langella P, Bachelet M, Masliah J, Seksik P, Policar C.

Inorg Chem. 2017 Mar 6;56(5):2545-2555. doi: 10.1021/acs.inorgchem.6b02695. Epub 2017 Feb 15.

PMID:
28198622
50.

Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.

Carvalho RD, Breyner N, Menezes-Garcia Z, Rodrigues NM, Lemos L, Maioli TU, da Gloria Souza D, Carmona D, de Faria AM, Langella P, Chatel JM, Bermúdez-Humarán LG, Figueiredo HC, Azevedo V, de Azevedo MS.

Microb Cell Fact. 2017 Feb 13;16(1):27. doi: 10.1186/s12934-017-0624-x.

Supplemental Content

Loading ...
Support Center